Evidence map›Paper›PMID 32103843›Full record

ArticleTetrahedron2019

Organocatalytic Strategy for Hydrophenolation of

Douglas L Orsi, M Ramu Yadav, Ryan A Altman

Abstract read
In one paragraph

Article in Tetrahedron, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Addition of Carboxylic Acids toOrganic letters · 2024
    Article
  4. A diselenide additive enables photocatalytic hydroalkoxylation ofChemical communications (Cambridge, England) · 2023
    Article
  5. Cu(II)-Catalyzed Unsymmetrical Dioxidation ofThe Journal of organic chemistry · 2022
    Article
  6. Article
  7. Article
  8. Acid-Catalyzed Hydrothiolation ofThe Journal of organic chemistry · 2021
    Article
  9. Cobalt-Catalyzed Selective Unsymmetrical Dioxidation ofThe Journal of organic chemistry · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Douglas L OrsiThe University of Kansas, Department of Medicinal Chemistry, Lawrence, KS 66045.
M Ramu YadavThe University of Kansas, Department of Medicinal Chemistry, Lawrence, KS 66045.
Ryan A AltmanThe University of Kansas, Department of Medicinal Chemistry, Lawrence, KS 66045.

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
Grant Supplement to Support Diversity in Health-Related ResearchR35GM124661 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI Ryan A Altman · 2017 to 2026
$4.1M
Avance II 500 High Performance Digital NMR Spectrometer SystemS10RR024664 · NCRR · UNIVERSITY OF KANSAS LAWRENCE · PI VANDERVELDE, DAVID G · 2007 to 2007
$468k
AVIII HD 400 NMR spectrometer to replace existing DRX 400S10OD016360 · OD · UNIVERSITY OF KANSAS LAWRENCE · PI DOUGLAS, JUSTIN TRIGALET · 2014 to 2014
$297k
NCRR NIH HHS S10 RR024664NIGMS NIH HHS P20 GM103418NIGMS NIH HHS R35 GM124661NIH HHS S10 OD016360
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32103843
PMCPMC7043310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.